neophyr 1000 ppm mol/mol gas zur medizinischen anwendung, druckverdichtet
sol spa (8085817) - stickstoffmonoxid - gas zur medizinischen anwendung, druckverdichtet - teil 1 - gas zur medizinischen anwendung, druckverdichtet; stickstoffmonoxid (16320) 1 milliliter
neophyr 450 ppm mol/mol gas zur medizinischen anwendung, druckverdichtet
sol spa (8085817) - stickstoffmonoxid - gas zur medizinischen anwendung, druckverdichtet - teil 1 - gas zur medizinischen anwendung, druckverdichtet; stickstoffmonoxid (16320) 0,45 milliliter
neophyr 225 ppm mol/mol gas zur medizinischen anwendung, druckverdichtet
sol spa (8085817) - stickstoffmonoxid - gas zur medizinischen anwendung, druckverdichtet - teil 1 - gas zur medizinischen anwendung, druckverdichtet; stickstoffmonoxid (16320) 0,225 milliliter
prednisolon 50 - 1a-pharma
1 a pharma gmbh (8013083) - prednisolon - tablette - prednisolon (00994) 50 milligramm
prednisolon 20 - 1 a - pharma
1 a pharma gmbh (8013083) - prednisolon - tablette - prednisolon 20.mg
prednisolon sandoz 5mg
sandoz pharmaceuticals gmbh (3060764) - prednisolon - tablette - prednisolon (00994) 5 milligramm
prednisolon "berco"
h e x a l aktiengesellschaft (3079284) - prednisolon - tablette - prednisolon (00994) 5 milligramm
prednisolon 5 mg tabletten lichtenstein
zentiva pharma gmbh (8075753) - prednisolon - tablette - prednisolon (00994) 5 milligramm
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - clopidogrel besilate - peripheral vascular diseases; stroke; myocardial infarction - antithrombotische mittel - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st-segment elevation acute myocardial infarction, in kombination mit ass bei medizinisch behandelten patienten, für die eine thrombolytische therapie. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. weitere informationen finden sie in abschnitt 5.
solution de glucose 20% stricker ad us. vet. solution pour perfusion pour vaches
biokema s.a. - glukose monohydricum - solution pour perfusion pour vaches - glucosum monohydricum 220 mg, phenolum liquefactum 2.0 mg, aqua ad iniectabile, ad solutionem pro 1 ml. - solution de glucose pour vaches - synthetika